-
2026 pilot grant awardees announced for the Mary Heersink Institute for Global HealthThe UAB Mary Heersink Institute for Global Health, in conjunction with the UAB Marnix E. Heersink Institute for Biomedical Innovation, proudly announces the fifth cohort of pilot grant awardees.Four innovative projects have received pilot funding to encourage collaboration between UAB investigators and international partners, tackling critical global health challenges.
-
DEAL kicks off with new cohort of high-potential staff of UAB and UAB MedicineTwenty-nine employees were selected for the 2026 cohort of the Developing Emerging Administrative Leaders program, which exposes promising staff members to the essential components of administrative and management positions across UAB. Meet the new class.
-
Being on a ventilator can be awful. These UAB doctors are working to make it better.A specialized training helps ICU specialists understand the complex dance of ventilator-assisted breathing as never before. Take a look behind the scenes of the first Multi-institutional Fundamentals of Mechanical Ventilation course at UAB — and see how educators are spreading the knowledge to doctors across the region.
-
Etomidate proves more effective for sedative use in patient intubationsSedative choice could improve patient outcomes in patients who have been intubated.
-
A fresh, multidimensional diagnosis for COPD identifies at-risk patients previously missedThe JAMA article is potentially practice-changing by enabling a diagnosis of COPD in individuals without airflow obstruction.
-
Alveolar macrophage cell surface receptor TREM2 promotes lung fibrosisThe finding of TREM2 as a critical regulator of macrophage-mediated fibrosis makes it a promising therapeutic target for intervention for lung fibrotic disease.
-
Allergies attacking? Avoid the pollen panic this spring with these tipsThree UAB professors offer expertise on springtime allergies and ways to mitigate pollen’s grip.
-
$100 million in contributions to transform UAB School of MedicineIn grateful recognition of a transformational $95 million lead gift from longtime University of Alabama at Birmingham supporter Marnix E. Heersink, M.D., the UAB School of Medicine will now be named the UAB Marnix E. -
16 faculty named winners of 2023 Dean’s Excellence AwardsSixteen remarkable faculty members have been named winners of the 2023 Dean’s Excellence Awards for Faculty. This award recognizes their exceptional achievements in teaching, research, service, mentorship, and fostering diversity within the Heersink School of Medicine. -
Antony named 2023 Dean's Excellence Award Winner in ResearchVeena Antony, M.D., professor in the Department of Medicine's Division of Pulmonary, Allergy, and Critical Care Medicine, is the senior faculty winner of the Dean's Excellence Award in Research. Antony's research is focused on environmental and translational medicine, cystic fibrosis, pleural disease, and lung injury. -
Blalock named 2022 Dean’s Excellence Award winner in MentorshipJ. Edwin “Ed” Blalock, Ph.D., professor in the Division of Pulmonary, Allergy and Critical Care Medicine, is the recipient of the senior faculty 2022 Dean’s Excellence Awards in Mentorship. He has been an active and vibrant faculty member at UAB for over 35 years. -
Blalock receives $7 million R35 grant for COPDJ. Edwin Blalock, Ph.D. -
Dransfield named interim chair of the Department of MedicineMark Dransfield, M.D., has been named interim chair of the UAB Department of Medicine, effective Sept. 1, 2024. -
Health Services Foundation awards $1.5 million in General Endowment Fund grants for 2024A 3D printer for prosthetics, navigation for patients on dialysis and a new electron microscope are three of the 11 projects to receive funding. The HSF-GEF faculty grants program is a way for UAB to support innovative ideas from its researchers and clinicians.
-
COPD and BPD: Inhalation of live Lactobacilli lessens lung inflammation and improves lung functionThis live biotherapeutic product, tested in mouse models, shows promise in addressing common pathways of lung disease progression.
-
12 graduate from UAB Medicine’s SAIL Spring 2024 programUAB Medicine’s Leadership Development Office recently recognized 12 individuals in its fourth cohort of Sharing Authentically to Inspire and Lead (SAIL). The spring 2024 graduates received their certificates on April 9.
-
New procedure rooms for interventional pulmonology will provide increased capacity and expedited careHitesh Batra, M.D., M.B.A. The UAB Interventional Pulmonology (IP) program will begin expansion to a new space in Fall 2024 to improve their clinical practices later in the year. -
UAB Pulmonary Fellowship Fosters Individualized LearningTracy Luckhardt, M.D. As the field of pulmonary medicine has evolved dramatically since 2020, faculty at UAB have revamped the fellowship training experience to better meet the needs of its learners. -
UAB Medicine Launches Nontuberculous Mycobacterial Disease ProgramBryan Garcia, M.D. According to the American Lung Association, the number of people living with Nontuberculous Mycobacterial (NTM) lung disease is on the rise, especially among women and older age groups. -
COPD: The effect of low-dose cadmium, a highly toxic metal, on airway epithelial cellsCigarette smoking is associated with COPD, and each cigarette has 2 to 3 micrograms of cadmium.
-
UAB Pulmonary Launches Environmental Lung Disease ClinicJoseph Barney, M.D., Crystal Stephens, CRNP, Kevin Dsouza, M.D., and Dhaval Raval, M.D. Joseph Barney, M.D., Kevin Dsouza, M.D., Dhaval Raval, M.D., and Crystal Stephens, CRNP have launched a new ELD clinic at UAB. -
Bodduluri Educates UAB in AI ParadigmSandeep Bodduluri, Ph.D.. Artificial intelligence (AI) is poised to revolutionize medical practice, and assistant professor Sandeep Bodduluri, Ph.D., will ensure UAB’s pulmonary physicians are ready for this transformation. -
New Leadership Joins Lung Health CenterMIcheal Wells, M.D., Amit Gaggar ,M.D., Ph.D., and Gabriella Oates, Ph.D. The UAB Lung Health Center has appointed three new pulmonary leaders to advance the treatment and study of lung health: Mike Wells, Amit Gaggar, and Gabriela Oates. -
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil CountsSurya Bhatt, M.D., MSPH, professor of medicine in the Division of Pulmonary, Allergy, & Critical Care Medicine, is the latest winner of the Heersink School of Medicine's Featured Discovery. This initiative celebrates important research from Heersink faculty members.
-
Surolia Recieves R01 Grant for Environmental Cadmium StudyRanu Surolia, Ph.D. -
COVID-19 bacteremic co-infection is a major risk factor for mortality, ICU admission, and mechanical ventilationNathaniel Erdmann, M.D., Ph.D., Amit Gaggar, M.D., and Matthew Might, Ph.D., are the latest winners of the Heersink School of Medicine's Featured Discovery. This initiative celebrates important research from Heersink faculty members.
-
Dupilumab lessens disease in COPD patients with type 2 inflammationChronic obstructive pulmonary disease patients with type 2 inflammation saw rapid and sustained improvements in their disease after treatment with the monoclonal antibody dupilumab.
-
Bhatt Investigates Impact of Dupilumab on COPD with Type 2 InflammationSurya Bhatt, M.D. Surya Bhatt, M.D., an associate professor in the UAB Division of Pulmonary, Allergy, and Critical Care Medicine, reported in the New England Journal of Medicine that patients with COPD and type 2 inflammation who received the biologic agent dupilumab had fewer exacerbations, better lung function, and less severe respiratory symptoms than those who received a placebo. -
Bhatt Researches New Measure of Airflow ObstructionSurya Bhatt, M.D. Considerable controversy exists on the best methods to diagnose airflow obstruction. -
Iyer Champions Palliative Care in Pulmonary SettingsWhile 92% of Americans say it’s important to discuss their wishes for end-of-life care, only 32% have had such a conversation.1 As an intensivist and pulmonary assistant professor, Anand Iyer, M.D., knows this quite well. He’s been having conversations about serious illness with patients and their families for over a decade.